Cerebras Systems (CBRS), a company known for designing AI chips and developing AI infrastructure, recently faced a significant drop in its stock price following its first earnings report as a publicly traded company. Despite concerns about near-term gross margins, several Wall Street analysts believe that the market may be overlooking the bigger picture when it comes to Cerebras.
Morgan Stanley, in particular, remains bullish on Cerebras. Analyst Joseph Moore reiterated his “Overweight” rating and raised his price target to $273 from $250. He believes that the softer margin outlook is due to conservative guidance rather than weakening demand. Moore sees Cerebras as strategically building one of the world’s largest AI cloud businesses for long-term success.
Founded in 2015 and headquartered in Sunnyvale, California, Cerebras has gained recognition in the AI hardware industry for its Wafer-Scale Engine (WSE), a processor designed to train and run AI models faster than conventional chips. The company’s CS-2 and CS-3 systems cater to cloud providers, enterprises, research institutions, and government-backed AI projects, positioning Cerebras as a formidable player in the AI infrastructure market with a market capitalization of $36.3 billion.
Since its IPO, CBRS has experienced significant volatility in its stock price, initially soaring but later facing a decline as investors reassessed the company’s valuation. However, momentum picked up after the post-IPO quiet period expired, with bullish analyst initiations reigniting optimism. The recent earnings report showed significant growth in core revenue, profitability, and partnerships, indicating a strong foundation for future success.
Looking ahead, Cerebras expects continued growth in core revenue and margins, with a focus on expanding its AI ecosystem through partnerships with companies like Amazon Web Services. While profitability may take time to materialize, the company’s robust financial position and strategic initiatives suggest a promising outlook for investors.
Despite the recent stock selloff, analysts like Morgan Stanley, Needham, and Wedbush remain bullish on Cerebras, emphasizing the company’s long-term potential in the AI market. With a consensus “Strong Buy” rating and price targets indicating significant upside potential, CBRS is poised for continued growth and success in the evolving AI landscape.
